By Craig Clough ( December 12, 2019, 8:39 PM EST) -- Juno Therapeutics and Sloan Kettering's bid for $752 million in damages over Kite Pharma's alleged infringement of a cancer immunotherapy patent is "just crazy," Kite's attorney told a California federal jury during closing arguments Thursday, noting the drug at issue has only logged $604 million in sales....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.